Key result
Chemotherapy-induced cardiomyopathy can occur years after treatment completion, and early recognition is important because complete recovery of cardiac function is possible in some cases.
This review highlights the importance of early recognition and treatment of chemotherapy-induced cardiomyopathy to facilitate potential recovery of cardiac function.
May warrant prolonged surveillance after chemotherapy; leaves open optimal protocols and recovery predictors in prospective studies.
Improvement in cancer therapy has led to an increasing number of cancer survivors, some of whom may suffer from the cardiotoxic effects of chemotherapy. Cardiomyopathy can occur years after completion of the chemotherapy and it is important to recognize this early, as complete recovery of cardiac function is possible in some cases. In this article we will review chemotherapy-induced cardiomyopathy and discuss its treatment options.
No takes yet. Share an insight, caveat, or question.
Yusuf et al. (2011) conducted a review in Chemotherapy-induced cardiomyopathy. Chemotherapy-induced cardiomyopathy can occur years after treatment completion, and early recognition is important because complete recovery of cardiac function is possible in some cases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: